Programme 13 February

07.00-08.30 Registration participants Registration desk MECC
08.30-10.00 Pleiotropy of hemostasis and coagulation proteases in the  pathogenesis of atherothrombosis
Chairmen: Pieter Reitsma, Henri Spronk
Room 0.4 / 0.5
  Athan Kuliopulos: Protease-Activated Receptors(PAR) in Cardiovascular Diseases. Room 0.4 / 0.5
  Wolfram Ruf: PAR signaling in macrophages Room 0.4 / 0.5
  Rory Koenen: Leukocytes and atherothrombosis Room 0.4 / 0.5
  Teresa Padro: Adiposity, inflammation and atherosclerosis Room 0.4 / 0.5
  Johan Heemskerk: Pleiotropic effects of platelets Room 0.4 / 0.5
  Uli Schotten: Hypercoagulability as substrate for atrial fibrillation Room 0.4 / 0.5

10.00-10.30

Coffee break

 
Exhibition area - Lobby

10.30-11.30 Workshops  
  Athan Kuliopulos
Room 0.1
  Wolfram Ruf Room 0.2
  Rory Koenen Room 0.3
  Teresa Padro Room 0.6 / 0.7
Johan Heemskerk Room 0.8
Uli Schotten Room 0.9
11.30-12.00 Short break Exhibition area - Lobby
12.00-13.00 Consensus discussion Room 0.4 / 0.5

13.00-14.00

Lunch

 
Exhibition area - Lobby
14.00-15.30 Target identification and new avenues in atherothrombosis management
Chairmen: Nigel Mackman, Paola van der Meijden
Room 0.4 / 0.5
  Gordon Lowe: Coagulation proteins and CVD: what did we know?  Room 0.4 / 0.5
  Jürgen Prochaska: Genetics and CVD risk stratification Room 0.4 / 0.5
  Thomas Renné: Should we inhibit the contact system?  Room 0.4 / 0.5
  Joost Meijers: Factor XI: The ultimate target for thrombosis prevention?  Room 0.4 / 0.5
  Alisa Wolberg: Transglutaminase activity and clot structure Room 0.4 / 0.5
  Trevor Baglin: Any more new anticoagulants?  Room 0.4 / 0.5

15.30-16.00

Coffee break

 
Exhibition area - Lobby
16.00-17.00 Workshops  
Gordon Lowe Room 0.1
  Jürgen Prochaska Room 0.2 
  Thomas Renné Room 0.3
  Joost Meijers Room 0.6 / 0.7
  Alisa Wolberg  Room 0.8
Trevor Baglin Room 0.9
17.00-17.30 Short Break Exhibition area - Lobby
17.30-18.30 Consensus discussion Room 0.4 / 0.5
19.30-20.30 Welcome reception  Museum aan het Vrijthof